| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |